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Calcium controls a number of critical events, including motility, secretion, cell invasion and egress by apicomplexan parasites 1 . Compared to animal 2 and plant cells 3 , the molecular mechanisms that govern calcium signalling in parasites are poorly understood. Here we show that the production of the phytohormone abscisic acid (ABA) controls calcium signalling within the apicomplexan parasite Toxoplasma gondii, an opportunistic human pathogen. In plants, ABA controls a number of important events, including environmental stress responses, embryo development and seed dormancy 4, 5 . ABA induces production of the second-messenger cyclic ADP ribose (cADPR), which controls release of intracellular calcium stores in plants 6 . cADPR also controls intracellular calcium release in the protozoan parasite T. gondii 7, 8 ; however, previous studies have not revealed the molecular basis of this pathway 9 . We found that addition of exogenous ABA induced formation of cADPR in T. gondii, stimulated calcium-dependent protein secretion, and induced parasite egress from the infected host cell in a density-dependent manner. Production of endogenous ABA within the parasite was confirmed by purification (using high-performance liquid chromatography) and analysis (by gas chromatography-mass spectrometry). Selective disruption of ABA synthesis by the inhibitor fluridone delayed egress and induced development of the slow-growing, dormant cyst stage of the parasite. Thus, ABA-mediated calcium signalling controls the decision between lytic and chronic stage growth, a developmental switch that is central in pathogenesis and transmission. The pathway for ABA production was probably acquired with an algal endosymbiont that was retained as a non-photosynthetic plastid known as the apicoplast. The plant-like nature of this pathway may be exploited therapeutically, as shown by the ability of a specific inhibitor of ABA synthesis to prevent toxoplasmosis in the mouse model.
Calcium-mediated protein secretion in T. gondii controls both motility and cell invasion, and previous studies have demonstrated that these processes utilize the second messenger cADPR, yet the signals triggering this pathway remain unresolved 7, 8 . In plants 6 , hydra 10 and sponges 11 , ABA stimulates release of intracellular calcium through elevation of the cyclic nucleotide cADPR. Addition of exogenous ABA proved to be a potent agonist of secretion in T. gondii as shown by the release of the protein MIC2 (microneme protein 2), a parasite adhesin that is discharged into the supernatant in response to increases in intracellular calcium (Fig. 1a) . Induction of MIC2 secretion by ABA was highly specific to (6)-ABA and was not induced by (-)-ABA, the precursor b-carotene, or retinoic acid (Fig. 1b) . In this regard, the response of T. gondii to ABA shows similar specificity to higher plants 5 . Treatment with ABA lead to a dose-dependent increase in the second messenger cADPR in T. gondii, suggesting that ABA may be a natural agonist for calcium signalling in parasites (Fig. 1c) . Finally, chelation of intracellular calcium in the parasite blocked secretion induced by ABA, confirming that it acts through release of an intracellular calcium pool (Fig. 1d) . Collectively, these results indicate that ABA in T. gondii controls release of calcium from intracellular stores through production of cADPR, thus paralleling the pathway seen in plants 6 , and early metazoans 10, 11 . Consistent with its physiological effects, ABA was detected in lysates of T. gondii by direct biochemical analyses. Extracts of 
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Treatment with (±)-ABA (nM) (kDa) Figure 1 | ABA induced cADPR production and calcium-dependent protein secretion by T. gondii. a, Protein secretion induced by ABA was compared to the positive control ethanol (EtOH) as detected by western blotting with anti-MIC2 (supernatant) and anti-b-galactosidase antibodies (cell pellet) 7, 8 . b, Induction of MIC2 secretion was specific for (6)-ABA and was not seen with (-)-ABA, b-carotene, or retinoic acid. c, cADPR production in T. gondii was increased by treatment with ABA. Student's t-test; *P , 0.02, **P , 0.01 versus control, mean 6 s.e.m., N 5 3 experiments. d, ABA-induced secretion required intracellular calcium. Treatment with the membrane permeable calcium chelator, BAPTA-AM, blocked ABA-induced MIC2 release, whereas non-permeant BAPTA had no effect. Cellular MIC2 (cMIC2) migrates slower owing to absence of processing. T. gondii were purified by high-performance liquid chromatography (HPLC) and analysed by gas chromatography to detect the methyl ester of ABA (methyl-ABA), which migrated with the same retention time (8 min) as the authentic methyl-ABA standard (Fig. 2a) . Mass spectrometric analysis of T. gondii samples yielded the expected product of mass-to-charge ratio (m/z) 190 as well as peaks at m/z 91 and 162, characteristic of cis-ABA, and m/z 91 and 134, characteristic of trans-ABA, as described previously 12 ( Fig. 2b and Supplementary Fig. 1 ). The slightly nosier spectrum obtained from T. gondii is consistent with the lower level of ABA found in the sample, nonetheless its signature unambiguously matches ABA. Similar levels of ABA were detected in parasite extracts using a highly specific ELISA (enzyme-linked immunosorbent assay) kit (Fig. 2c ). To confirm that ABA was indeed synthesized by the parasite, we used the herbicide fluridone, an inhibitor that specifically blocks phytoene destaurase activity, and hence prevents synthesis of ABA by the indirect pathway that predominates in plants 5 . Treatment with fluridone reduced the level of ABA in parasites by more than fourfold (Fig. 2c ). Interestingly, when the level of ABA was monitored during one cycle of intracellular growth, it remained relatively constant during the first 30-36 h and then spiked shortly before egress of parasites from the infected host cell, which begins around 40-44 h (Fig. 2d) .
Toxoplasma is an obligate intracellular pathogen and following invasion, the parasite replicates by binary fission within a vacuole, ultimately leaving the depleted host cell by active egress. Intracellular calcium is central for several of these steps, leading us to examine whether ABA-dependent calcium signalling was essential for growth in vitro. Treatment of parasite cultures with increasing concentrations of fluridone led to inhibition of parasite growth (effector concentration for half-maximum response, EC 50 , ,15 mM; Fig. 3a) . Surprisingly, fluridone treatment did not block invasion or replication, but instead inhibited exit of mature parasites from the infected cell. Whereas parasites had naturally egressed by ,60 h, those treated with 15 mM fluridone were delayed, and those treated with 50 mM fluridone were completely blocked out to 84 h (Fig. 3b) , after which the integrity of the monolayer declined (data not shown). Previous studies have implicated calcium signalling in parasite egress from infected cells 13, 14 , and the rapid increase in ABA concentrations in the parasite just before egress (Fig. 2d) suggested this molecule may be the natural signal for activating exit. Consistent with this, when exogenous ABA was added to late-stage vacuoles, it induced premature egress (Fig. 3c) . Finally, ABA was able to overcome the inhibition of egress caused by treatment with fluridone ( Fig. 3d) , consistent with it being able to bypass the metabolic block in biosynthesis. Although the responses to exogenously added ABA are somewhat modest, this may reflect the relatively low permeability of the charged anion that exists at physiological pH (pK a 4.8), and the fact that it has to cross several membranes to reach the parasite. Whether ABA produced by the parasite accumulates within the parasite or is exported to the parasite-containing vacuole is unknown, and the mechanism(s) whereby ABA is sensed remain to be elucidated. Nonetheless, these results indicate that ABA is a natural agonist for host cell egress and that in the absence of its production, parasites remain quiescent within the host cell. Toxoplasma undergoes two fundamentally different forms of growth within host cells: (1) the lytic cycle described above, which rapidly amplifies parasite numbers, and (2) differentiation into semidormant cysts that are long-lived. These adaptations serve different roles during infection, the first leading to active dissemination and the second resulting in a life-long chronic infection. The decision to undergo this developmental switch is poorly understood, but is thought to be a response to stress. In fluridone-treated cultures, parasites that failed to egress from the host cell started to develop into tissue cysts, as shown by staining with the cyst-wall specific lectin from Dolichos biflorus (DBL) (Fig. 4a) . Tissue cysts produced by treatment with fluridone were positive for several stage-specific cyst markers, including DBL and the cyst antigens CST1 (ref. 15 ) and BAG1 (ref. 16) (Fig. 4b) . Ultrastructural examination of the cysts formed by fluridone treatment revealed hallmark features of parasites within cysts, including a posterior positioned nucleus, amylopectin granules, dense rhoptries and a convoluted cyst wall (Fig. 4c) . Fluridone treatment also enhanced the response of parasites to alkaline pH stress ( Supplementary Fig. 2 ), a common experimental method used to induce differentiation 17 . In addition to blocking egress in vitro, fluridone treatment was also able to prevent lethal infection in laboratory mice, which provide an excellent model for toxoplasmosis (Fig. 4d) . Imaging of parasite dissemination in vivo using a luciferase expressing strain revealed that fluridone treatment greatly reduced parasite burdens during in vivo infection in the mouse (Fig. 4e, Supplementary Fig. 3 ), which led to decreased cyst formation in the central nervous system during chronic infection (Fig. 4f) . Fluridone is a registered herbicide that has low toxicity to mammalian cells, owing to the absence of this biosynthetic pathway in animals. Our results, combined with a previous patent indicating that it is also effective against malaria 18 , suggest that this selectivity may be exploited for development of improved antiparasitic drugs. ABA synthesis in plants proceeds from isoprenoids using an indirect pathway that flows through b-carotene in the plastid 5 . T. gondii utilizes a non-mevalonate pathway for isoprenoid biosynthesis 19 , which occurs in the apicoplast, a remnant organelle derived from an algal endosymbiont 20 . The sensitivity of T. gondii to fluridone indicates that it contains an indirect pathway for ABA production, which depends on the plastid, rather than the direct pathway found in fungi 5 , thus providing an additional explanation for the essential nature of the apicoplast 20 . Although the T. gondii genome (http://ToxoDB.org) contains several candidates with similarity to ABA synthesis genes in higher plants (that is, ABA1, ABA2 and ABA3) 5 , phylogenetic and domain analyses do not provide unambiguous assignments of these orthologues (data not shown). This divergence is not unexpected, given that the plant-like nature of apicomplexans is based on acquisition of an early branching algal endosymbiont 21 . Although algae have also been shown to make ABA 22, 23 and respond to this hormone 24 , the precise pathways and genes involved in ABA production by algae are not established. Future studies aimed at defining the pathway for production of ABA in T. gondii may provide further insight into the role of this hormone outside of higher plants.
Our findings demonstrate the conservation of a common plantlike, calcium-signalling pathway in the protozoan parasite T. gondii. Production of ABA is a density-dependent signal that influences the decision for lytic growth versus dormant development in T. gondii. ABA has recently been shown to regulate gene expression by altering messenger RNA translation 25 , and to activate G-protein coupled receptor signalling 26 in plants, indicating that it has additional important functions beyond calcium signalling. These ABA-response genes are conserved in T. gondii, and the related parasite Plasmodium spp. (http://ApiDB.org), where they may play analogous roles in ABA-mediated signalling and development. Disruption of ABA-mediated signalling in parasites offers a promising new target for development of improved interventions aimed at combating infection with apicomplexan parasites.
METHODS SUMMARY
Growth and egress assays. Intracellular parasite growth was monitored using b-galactosidase activity 7 , or by microscopic examination determination of the number of parasites per vacuole 13, 17 . Egress was monitored by the percentage of intact vacuoles after culturing for defined intervals with and without fluridone, followed by treatment with ABA. Secretion assay. Calcium-dependent secretion was monitored by release of MIC2 (refs 7, 27) , with b-galactosidase as a cell-loading and non-specific lysis control. ABA purification and analysis. ABA was extracted from parasites, purified by HPLC, converted to methyl-ABA 28 , and analysed by tandem mass spectrometry using an Agilent Technologies GC-MS instrument to detect the diagnostic fragments 12 . ABA detection by ELISA. ABA concentrations in parasite extracts were determined by ELISA using the Phytodetek ABA Test Kit (Agdia) after subtraction of the background level of ABA in cultured host cells processed in parallel, and expressed as intracellular concentrations 29 . Cyclic ADPR. Freshly harvested parasites were snap frozen at -80 uC, extracted, and cADPR levels determined as described previously 8 . In vitro differentiation. Cyst formation was monitored following treatment with fluridone under normal culture conditions as detected using FITC-labelled DBL (Sigma) or antibodies to the cyst antigens CST1 (ref. 15) or BAG1 (ref. 16 ). Transmission electron microscopy was performed as described previously 17 . Mouse infections. BALB/c mice were infected with type II strain PTG strain by intraperitoneal (i.p.) injection and treated with fluridone by daily i.p. injection for 12 d. To monitor tissue burdens, mice were challenged with the luciferase expressing Pru-Luc strain and imaged as described previously 30 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
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